Kara M. Tanabe

Expression of multidrug transporter<i>MRP4/ABCC4</i>is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan<i>in vitro</i>

Murray D. Norris, Janice Smith, Kara M. Tanabe et al. · Molecular Cancer Therapeutics · 2005 · 136 citations · Full text

Medicine, Oncology, Pharmacology +14

Modification of In Vivo and In Vitro T- and B-Cell-Mediated Immune Responses by the<i>Pseudomonas aeruginosa</i>Quorum-Sensing Molecule<i>N</i>-(3-Oxododecanoyl)-<scp>l</scp>-Homoserine Lactone

Adam Ritchie, Andrew O. Yam, Kara M. Tanabe et al. · Infection and Immunity · 2003 · 104 citations · Full text

Life Sciences, Immunology, Microbiology +17

Mechanism of Selectivity of an Angiogenesis Inhibitor From Screening a Genome-Wide Set of Saccharomyces cerevisiae Deletion Strains

Pierre J. Dilda, Anthony S. Don, Kara M. Tanabe et al. · JNCI Journal of the National Cancer Institute · 2005 · 36 citations · Full text

Medicine, Molecular Biology, Pharmacology +14